Skip to main content

Advertisement

SpringerLink
Log in

An analysis of psoriasis hospitalisation in Thailand

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Psoriasis hospitalisation is not frequently reported. The objective of this study was to determine (1) the clinical, laboratory and treatment features of patients with psoriasis hospitalised due to flare-up and (2) other causes of admission of patients with psoriasis. We retrospectively reviewed data on 48 patients admitted due to psoriasis flare-up and 1908 patients with psoriasis admitted due to concomitant illnesses or comorbidities. The study period was 2005–2021. The latter group was compared with 821,804 patients without psoriasis admitted during the period. Of the 48 cases, 37.5% had erythroderma, and 62.5% had generalised pustular psoriasis (GPP). Women (68.8%) predominated, especially in the GPP group (76.7%). The mean age of admission with erythroderma (44.8 years) was higher than for GPP (32.1 years). Infection was the main trigger for psoriasis flare-up (46%). Abnormalities in liver function tests were found in 33.3% of the cases. These abnormalities usually subsided 1–2 months after skin improvement (83.4%). Acitretin was the most prescribed drug for GPP (81.4%), whereas topical treatment alone (50%) was the most frequent erythroderma therapy. Intensive care was needed by 9.3% of patients with GPP. In the psoriasis group admitted due to concomitant illnesses or comorbidities, admission due to digestive and infectious causes was significantly higher for psoriasis patients. Our study showed that trend of psoriasis admission due to disease flare-up was not significantly changed even in the era of biologics. We believed that patient education on avoiding the common precipitating factors of psoriasis flare-up and good self-care is mandatory to reduce the risk of hospitalisation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM (2020) National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ 369:m1590

    Article  PubMed  PubMed Central  Google Scholar 

  2. Mrowietz U, Kragballe K, Reich K, Spuls P, Griffiths CE, Nast A et al (2011) Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res 303(1):1–10

    Article  CAS  PubMed  Google Scholar 

  3. Yeung H, Takeshita J, Mehta NN, Kimmel SE, Ogdie A, Margolis DJ et al (2013) Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA Dermatol 149(10):1173–1179

    Article  PubMed  PubMed Central  Google Scholar 

  4. Rodriguez-Jato Q, Pereira AR, Batalla A, Abalde MT, Salgado-Boquete L, Martinez-Reglero C et al (2021) Hospitalization in patients with psoriasis: impact of biological therapies on temporal evolution. J Drugs Dermatol 20(2):208–214

    Article  PubMed  Google Scholar 

  5. Prodanovich S, Kirsner RS, Taylor JR (2000) Treatment of patients hospitalized for psoriasis. Dermatol Clin. 18(3):425–435

    Article  CAS  PubMed  Google Scholar 

  6. Austad SS, Athalye L (2022) Exfoliative dermatitis. StatPearls. StatPearls Publishing LLC., Treasure Island, FL

    Google Scholar 

  7. Langenbruch A, Mohr N, Kirsten N, Reich K, von Kiedrowski R, Strömer K et al (2021) Quality of psoriasis care in Germany—results from the nationwide health care studies PsoHealth 2004–2017. J Eur Acad Dermatol Venereol 35(7):1536–1542

    Article  CAS  PubMed  Google Scholar 

  8. Polivka L, Oubaya N, Bachelez H, Paul C, Richard MA, Beylot-Barry M et al (2018) Trends in hospitalization rates for psoriasis flares since the introduction of biologics: a time series in France between 2005 and 2015. J Eur Acad Dermatol Venereol 32(11):1920–1929

    Article  CAS  PubMed  Google Scholar 

  9. Hsu DY, Gordon K, Silverberg JI (2016) The inpatient burden of psoriasis in the United States. J Am Acad Dermatol 75(1):33–41

    Article  PubMed  Google Scholar 

  10. Nelson AA, Pearce DJ, Fleischer AB Jr, Balkrishnan R, Feldman SR (2005) Inpatient management of severe psoriasis. J Drugs Dermatol 4(5):564–570

    PubMed  Google Scholar 

  11. Finet A, Viguier M, Chazouillères O, Amatore F, Paul C, Richard MA et al (2016) Liver test abnormalities in patients admitted for severe psoriasis: prevalence and associated risk factors. J Eur Acad Dermatol Venereol 30(10):1742–1748

    Article  CAS  PubMed  Google Scholar 

  12. Miyachi H, Konishi T, Kumazawa R, Matsui H, Shimizu S, Fushimi K et al (2021) Treatments and outcomes of generalized pustular psoriasis: a cohort of 1516 patients in a nationwide inpatient database in Japan. J Am Acad Dermatol 86:1266–1274

    Article  PubMed  Google Scholar 

  13. Hanna ML, Singer D, Bender SD, Valdecantos WC, Wu JJ (2021) Characteristics of hospitalizations and emergency department visits due to generalized pustular psoriasis in the United States. Curr Med Res Opin 37:1697

    Article  CAS  PubMed  Google Scholar 

  14. Borges-Costa J, Silva R, Gonçalves L, Filipe P, Soares de Almeida L, Marques Gomes M (2011) Clinical and laboratory features in acute generalized pustular psoriasis: a retrospective study of 34 patients. Am J Clin Dermatol 12(4):271–276

    Article  PubMed  Google Scholar 

  15. Tosukhowong T, Kiratikanon S, Wonglamsam P, Netiviwat J, Innu T, Rujiwetpongstorn R et al (2021) Epidemiology and clinical features of pustular psoriasis: a 15-year retrospective cohort. J Dermatol 48(12):1931–1935

    Article  CAS  PubMed  Google Scholar 

  16. Zhou J, Luo Q, Cheng Y, Wen X, Liu J (2021) An update on genetic basis of generalized pustular psoriasis (review). Int J Mol Med. https://doi.org/10.3892/ijmm.2021.4951

    Article  PubMed  PubMed Central  Google Scholar 

  17. Viguier M, Allez M, Zagdanski AM, Bertheau P, de Kerviler E, Rybojad M et al (2004) High frequency of cholestasis in generalized pustular psoriasis: evidence for neutrophilic involvement of the biliary tract. Hepatology 40(2):452–458

    Article  PubMed  Google Scholar 

  18. Allez M, Roux ME, Bertheau P, Erlinger S, Degott C, Morel P et al (2000) Recurrent cholestatic jaundice associated with generalized pustular psoriasis: evidence for a neutrophilic cholangitis. J Hepatol 33(1):160–162

    Article  CAS  PubMed  Google Scholar 

  19. Cabanillas M, Pérez-Pérez L, Sánchez-Aguilar D, Toribio J (2006) Generalized pustular psoriasis and cytolytic hepatitis associated with neutrophilic cholangitis. Actas Dermosifiliogr 97(5):330–333

    Article  PubMed  Google Scholar 

  20. Robinson A, Van Voorhees AS, Hsu S, Korman NJ, Lebwohl MG, Bebo BF Jr et al (2012) Treatment of pustular psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol 67(2):279–288

    Article  CAS  PubMed  Google Scholar 

  21. Hoegler KM, John AM, Handler MZ, Schwartz RA (2018) Generalized pustular psoriasis: a review and update on treatment. J Eur Acad Dermatol Venereol 32(10):1645–1651

    Article  CAS  PubMed  Google Scholar 

  22. Chularojanamontri L, Silpa-Archa N, Wongpraparut C, Limphoka P (2019) Long-term safety and drug survival of acitretin in psoriasis: a retrospective observational study. Int J Dermatol 58(5):593–599

    Article  CAS  PubMed  Google Scholar 

  23. Choon SE, Navarini AA, Pinter A (2022) Clinical course and characteristics of generalized pustular psoriasis. Am J Clin Dermatol 23(Suppl 1):21–29

    Article  PubMed  PubMed Central  Google Scholar 

  24. Vaidya TS, Lewallen RS, Feldman SR (2016) Erythrodermic psoriasis and severe hypotension requiring intensive care unit hospitalization: poor treatment outcome as a result of poor adherence. J Dermatol Treat 27(2):134–135

    Article  Google Scholar 

  25. Schaefer C, Mamolo C, Cappelleri JC, Daniel S, Le C, Tatulych S et al (2017) Treatment patterns and outcomes among adults admitted to hospital in the U.K. due to plaque or erythrodermic psoriasis. Br J Dermatol 177(3):e52–e54

    Article  CAS  PubMed  Google Scholar 

  26. Green MS, Prystowsky JH, Cohen SR, Cohen JI, Lebwohl MG (1996) Infectious complications of erythrodermic psoriasis. J Am Acad Dermatol 34(5 Pt 2):911–914

    Article  CAS  PubMed  Google Scholar 

  27. Rosenbach M, Hsu S, Korman NJ, Lebwohl MG, Young M, Bebo BF Jr et al (2010) Treatment of erythrodermic psoriasis: from the medical board of the National Psoriasis Foundation. J Am Acad Dermatol 62(4):655–662

    Article  CAS  PubMed  Google Scholar 

  28. Nair KM, Kannayiram SS, Guraya A, Idolor ON, Aihie OP, Sanwo EJ et al (2020) Reasons for hospitalization of psoriasis patients: a report from the national inpatient sample. Cureus 12(12):e12271

    PubMed  PubMed Central  Google Scholar 

  29. Vaengebjerg S, Skov L, Egeberg A, Loft ND (2020) Prevalence, incidence, and risk of cancer in patients with psoriasis and psoriatic arthritis: a systematic review and meta-analysis. JAMA Dermatol 156(4):421–429

    Article  PubMed  PubMed Central  Google Scholar 

  30. Miller IM, Ellervik C, Yazdanyar S, Jemec GB (2013) Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors. J Am Acad Dermatol 69(6):1014–1024

    Article  PubMed  Google Scholar 

  31. Yiu ZZN, Parisi R, Lunt M, Warren RB, Griffiths CEM, Langan SM et al (2021) Risk of hospitalization and death due to infection in people with psoriasis: a population-based cohort study using the clinical practice research datalink. Br J Dermatol 184(1):78–86

    Article  CAS  PubMed  Google Scholar 

  32. Wakkee M, de Vries E, van den Haak P, Nijsten T (2011) Increased risk of infectious disease requiring hospitalization among patients with psoriasis: a population-based cohort. J Am Acad Dermatol 65(6):1135–1144

    Article  PubMed  Google Scholar 

  33. Hsu DY, Gordon K, Silverberg JI (2016) Serious infections in hospitalized patients with psoriasis in the United States. J Am Acad Dermatol 75(2):287–296

    Article  PubMed  Google Scholar 

  34. Chaiyabutr C, Jiamton S, Silpa-Archa N, Wongpraparut C, Wongdama S, Chularojanamontri L (2022) Retrospective study of psoriasis in people living with HIV: Thailand’s experience. J Dermatol. https://doi.org/10.1111/1346-8138.16352

    Article  PubMed  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

  1. Department of Dermatology, Faculty of Medicine, Siriraj Hospital, Mahidol University, 2 Wanglang Road, Bangkok Noi, Bangkok, 10700, Thailand

    Chayada Chaiyabutr, Narumol Silpa-archa, Chanisada Wongpraprarut, Surachanee Likittanasombat, Phumithep Phumariyapong & Leena Chularojanamontri

Authors
  1. Chayada Chaiyabutr
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Narumol Silpa-archa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chanisada Wongpraprarut
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Surachanee Likittanasombat
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Phumithep Phumariyapong
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Leena Chularojanamontri
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

The authors confirm contribution to the paper as follows; study conception and design: CC and LC; data collection: SL and PP; analysis and interpretation of results: CC and SL; draft manuscript preparation: CC and LC in consultation with CW and NS-a. All authors reviewed the results and approved the final version of the manuscript.

Corresponding author

Correspondence to Leena Chularojanamontri.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chaiyabutr, C., Silpa-archa, N., Wongpraprarut, C. et al. An analysis of psoriasis hospitalisation in Thailand. Arch Dermatol Res 315, 779–786 (2023). https://doi.org/10.1007/s00403-022-02429-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-022-02429-w

Keywords

Search

Navigation